Risk adapted dose-intensified postoperative Tomotherapy RT in prostate cancer using a SIB.

被引：0
|
作者：
Beck, M. [1 ]
Barelkowski, T. [1 ]
Thieme, A. H. [1 ]
Wecker, S. [1 ]
Kaul, D. [1 ]
Wlodarczyk, W. [1 ]
Budach, V. [1 ]
Wust, P. [1 ]
Ghadjar, P. [1 ]
机构：
[1] Charite, Dept Radiat Oncol, Berlin, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)31760-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1325
引用
收藏
页码：S710 / S711
页数：2
相关论文
共 50 条
  • [21] Dose accumulation with deformable image registration method using helical tomotherapy images for prostate cancer
    Thongsuk, Warit
    Chitapanarux, Imjai
    Wanwilairat, Somsak
    Nobnop, Wannapha
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2020, 19 (01) : 25 - 29
  • [22] Compare OARs dose in postoperative high-risk prostate cancer patients using IMRT and VMAC technique
    Chen, Y.
    Chou, L.
    Wang, T.
    Liu, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1207 - S1208
  • [23] SIMULTANEOUS INTEGRATED BOOST-IMRT WITH SERIAL TOMOTHERAPY VS 3DIMENSIONAL-CONFORMAL HIGH-DOSE RT IN PROSTATE CANCER
    Papaleo, A.
    Leone, A.
    Russo, D.
    Cavalera, E.
    Natali, M. G.
    Santantonio, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S388 - S389
  • [24] Use of EORTC Target Definition Guidelines for Dose-Intensified Salvage Radiation Therapy for Recurrent Prostate Cancer: Results of the Quality Assurance Program of the Randomized Trial SAKK 09/10
    Sassowsky, Manfred
    Gut, Philipp
    Hoelscher, Tobias
    Hildebrandt, Guido
    Mueller, Arndt-Christian
    Najafi, Yousef
    Kohler, Goetz
    Kranzbuehler, Helmut
    Guckenberger, Matthias
    Zwahlen, Daniel R.
    Azinwi, Ngwa C.
    Plasswilm, Ludwig
    Takacs, Istvan
    Reuter, Christiane
    Sumila, Marcin
    Manser, Peter
    Ost, Piet
    Boehmer, Dirk
    Pilop, Christiane
    Aebersold, Daniel M.
    Ghadjar, Pirus
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03): : 534 - 541
  • [25] Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking
    Raffaella Lucchini
    Denis Panizza
    Riccardo Ray Colciago
    Veronica Vernier
    Martina Camilla Daniotti
    Valeria Faccenda
    Stefano Arcangeli
    [J]. Radiation Oncology, 16
  • [26] Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking
    Lucchini, Raffaella
    Panizza, Denis
    Colciago, Riccardo Ray
    Vernier, Veronica
    Daniotti, Martina Camilla
    Faccenda, Valeria
    Arcangeli, Stefano
    [J]. RADIATION ONCOLOGY, 2021, 16 (01)
  • [27] Dose-intensified versus conventional dose-salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: Six-year outcomes of the SAKK 09/10 randomized phase III trial.
    Ghadjar, Pirus
    Hayoz, Stefanie
    Bernhard, Juerg
    Zwahlen, Daniel Rudolf
    Hoelscher, Tobias
    Gut, Philipp
    Polat, Bulent
    Hildebrandt, Guido
    Mueller, Arndt-Christian
    Plasswilm, Ludwig
    Papachristofilou, Alexandros
    Schaer, Corinne
    Sumila, Marcin
    Zaugg, Kathrin
    Guckenberger, Matthias
    Ost, Piet
    Reuter, Christiane
    Bosetti, Davide Giovanni
    Khanfir, Kaouthar
    Aebersold, Daniel M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [28] Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10
    Ghadjar, Pirus
    Hayoz, Stefanie
    Bernhard, Juerg
    Zwahlen, Daniel R.
    Hoelscher, Tobias
    Gut, Philipp
    Guckenberger, Matthias
    Hildebrandt, Guido
    Mueller, Arndt-Christian
    Plasswilm, Ludwig
    Papachristofilou, Alexandros
    Stalder, Lukas
    Biaggi-Rudolf, Christine
    Sumila, Marcin
    Kranzbuehler, Helmut
    Najafi, Yousef
    Ost, Piet
    Azinwi, Ngwa C.
    Reuter, Christiane
    Bodis, Stephan
    Kaouthar, Khanfir
    Wust, Peter
    Thalmann, George N.
    Aebersold, Daniel M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) : 4158 - +
  • [29] A randomised phase III trial comparing two dose-dense, dose-intensified approaches (EPC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto)
    Schneeweiss, Andreas
    Moebus, Volker
    Tesch, Hans
    Hanusch, Claus
    Denkert, Carsten
    Luebbe, Kristina
    Huober, Jens Bodo
    Klare, Peter
    Kummel, Sherko
    Untch, Michael
    Kast, Karin
    Jackisch, Christian
    Thomalla, Jorg
    Heppner, Barbara Ingold
    Blohmer, Jens U.
    Rezai, Mandi
    Frank, Matthias
    Nekljudova, Valentina
    Von Minckwitz, Gunter
    Loibl, Sibylle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] A randomised phase III trial comparing two dose-dense, dose-intensified approaches (ETC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto)
    Schneeweiss, A.
    Moebus, V.
    Tesch, H.
    Hanusch, C.
    Denkert, C.
    Luebbe, K.
    Huober, J.
    Klare, P.
    Kuemmel, S.
    Untch, M.
    Kast, K.
    Jackisch, C.
    Ingold-Heppner, B.
    Thomalla, J.
    Blohmer, J-U
    Rezai, M.
    Nekljudova, V.
    von Minckwitz, G.
    Loibl, S.
    [J]. CANCER RESEARCH, 2017, 77
12345